Skip to search formSkip to main contentSkip to account menu

naxagolide

Known as: 4-propyl-9-hydroxy-1,2,3,4a,5,6-hexahydronaphthoxazine, 4-propyl-9-hydroxynaphthoxazine, (+)-4-propyl-9-hydroxynaphthoxazine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Background: Glioblastoma multiforme (GBM) is a common and lethal cancer of the central nervous system. This cancer is difficult… 
2010
2010
Clinical trials have demonstrated positive proof of efficacy of dual metabotropic glutamate receptor 2/3 (mGluR2/3) agonists in… 
Highly Cited
2006
Highly Cited
2006
[11C]‐(+)‐PHNO (4‐propyl‐9‐hydroxynaphthoxazine) is a new agonist radioligand that provides a unique opportunity to measure the… 
Highly Cited
1996
Highly Cited
1996
  • M. Kleven, W. Koek
  • The Journal of pharmacology and experimental…
  • 1996
  • Corpus ID: 13451639
Spontaneous eye blink rate was assessed in cynomolgus monkeys treated intramuscularly with the high-efficacy dopamine (DA… 
1993
1993
  • E. Domino, J. Sheng
  • The Journal of pharmacology and experimental…
  • 1993
  • Corpus ID: 22869683
A series of dopamine agonists were studied on contraversive circling behavior in seven 1-methyl-4-phenyl-1,2,3,6… 
1990
1990
4‐‐Propyl‐9‐hydroxynaphthoxazine, or MK‐458 (HPMC), a selective, nonergot D2 agonist administered orally twice a day in sustained… 
1990
1990
Metabolism of dopazinol (DZ) by liver microsomes from control and phenobarbital- and 3-methylcholanthrene-treated rats has been… 
1985
1985
The intrinsic activity of the potent dopamine (DA) agonist 4-propyl-9-hydroxynaphthoxazine [(+)-PHNO] was examined in receptor… 
Highly Cited
1984
Highly Cited
1984
The (+)-enantiomer of 1,2,3,4a,5,6-hexahydro-9-hydroxy-4-n-propyl-4H-naphth[1,2-b][ 1,4]-oxazine [(+)-PHNO] is demonstrated to be…